Immuneering IMRX
NASDAQ IMRX
$3.72 -0.09 (-2.23%)
As of: Oct 23, 2026 · 3:49 PM EDT

Immuneering (IMRX) Cash & Current Investments (2020 - 2026)

Updated

Immuneering (IMRX) recorded Cash & Current Investments of $149.9 million in Q2 2026, up 468.8% from $26.36 million a year earlier but down 4.3% from the prior quarter.

Analysis

Immuneering (IMRX) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Immuneering reported Cash & Current Investments of $172.83 million, up 378.2% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 36.0% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $36.14 million in FY2024 (-57.8%), $85.67 million in FY2023 (-18.8%), $105.52 million in FY2022 (-29.3%) and $149.2 million in FY2021 (+302.3%).
  • Quarterly Cash & Current Investments has ranged from $26.36 million in Q2 2025 to $227.56 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 165.2% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 468.8% in Q2 2026, against a decline of 57.8% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $156.69 million (Q1 2026), $172.83 million (Q4 2025) and $227.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,133.26 Bn 1,101.85 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.92 Bn 555.78 Bn 17.30 Bn 17.23 Bn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn 6.57 Bn
4 Merck 358.38 Bn 312.76 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 293.00 Bn 256.99 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.76 Bn 239.44 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.88 Bn 193.27 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.26 Bn 169.45 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.34 Bn 117.99 Bn 10.94 Bn 11.70 Bn
10 Immuneering 241.00 Mn -465.99 Mn - 149.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 149.90 Mn
Mar 31, 2026 156.69 Mn
Dec 31, 2025 172.83 Mn
Sep 30, 2025 227.56 Mn
Jun 30, 2025 26.36 Mn
Mar 31, 2025 35.87 Mn
Dec 31, 2024 36.14 Mn
Sep 30, 2024 50.66 Mn
Jun 30, 2024 59.73 Mn
Mar 31, 2024 71.28 Mn
Dec 31, 2023 85.67 Mn
Sep 30, 2023 97.24 Mn
Jun 30, 2023 108.99 Mn
Mar 31, 2023 91.54 Mn
Dec 31, 2022 105.52 Mn
Sep 30, 2022 117.20 Mn
Jun 30, 2022 128.10 Mn
Mar 31, 2022 137.77 Mn
Dec 31, 2021 149.20 Mn
Sep 30, 2021 149.48 Mn
API Access

Immuneering Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IMRX&period=max&api_key=YOUR_API_KEY